Add office photos
![Zydus Lifesciences logo](https://static.ambitionbox.com/assets/v2/images/rs:fit:200:200:false:false/bG9jYWw6Ly8vbG9nb3Mvb3JpZ2luYWxzL3p5ZHVzLWNhZGlsYS5qcGc.webp)
Engaged Employer
Zydus Lifesciences
![](https://static.ambitionbox.com/static/middleNavbar/arrow-black.png)
4.1
based on 5.9k Reviews
![](https://static.ambitionbox.com/static/play.png)
Video summary
Company Overview
Associated Companies
Company Locations
Working at Zydus Lifesciences
Company Summary
In 1995 we dedicated ourselves to the welfare of people and depicted our commitment with a heart-to-heart portrait. Today, with our evolved brand identity, this commitment emerges stronger than ever.
Overall Rating
4.1/5
based on 5.9k reviews
![highly rated categories](https://static.ambitionbox.com/static/arrow_upward.png)
5% above
industry average
![highly rated categories](https://static.ambitionbox.com/static/helpful.png)
Highly rated for ![](https://static.ambitionbox.com/alpha/community/assets/infoUnfilled.svg)
Salary, Skill development, Job security
Work Policy
![Work from office](https://static.ambitionbox.com/static/icons/forms/office.png)
Work from office
83% employees reported
![Monday to Saturday](https://static.ambitionbox.com/static/calender.png)
Monday to Saturday
60% employees reported
![Strict timing](https://static.ambitionbox.com/static/clock.png)
Strict timing
56% employees reported
![No travel](https://static.ambitionbox.com/static/travel.png)
No travel
47% employees reported
View detailed work policy
Top Employees Benefits
Job/Soft skill training
358 employees reported
Office cab/shuttle
352 employees reported
Health insurance
325 employees reported
Cafeteria
130 employees reported
View all benefits
About Zydus Lifesciences
Founded in1952 (73 yrs old)
India Employee Count10k-50k
Global Employee Count10k-50k
India HeadquartersAhmedabad, India, India
Websitezyduslife.com
Primary Industry
Other Industries
![](https://static.ambitionbox.com/static/company-summary-video-thumbnail.png)
View in video summary
Zydus Lifesciences Limited formerly knowns as Cadila Healthcare Limited, a leading Indian Pharmaceutical company is a fully integrated, global healthcare provider. With in-depth domain expertise in the field of healthcare, it has strong capabilities across the spectrum of the pharmaceutical value chain. From formulations to active pharmaceutical ingredients. Zydus has earned a reputation amongst Indian pharmaceutical companies for providing comprehensive and complete healthcare solutions. One of the salient features of Zydus is its rich history and lineage. The origin of the company dates all the way back to the 1950s. The company was founded in the year 1952 by Mr. Ramanbhai B. Patel (late), a first-generation entrepreneur and a doyen in the field of Indian Pharmaceuticals. In 1995, the group was restructured and thus was formed Cadila Healthcare under the aegis of the Zydus group. From a humble turnover of Rs. 250 crores in 1995 the group witnessed significant financial growth and registered a turnover of over Rs. 15,000 crores in FY-21. Adhering to its brand promise of being dedicated to life in all its dimensions, Zydus continues to innovate with an unswerving focus to address unmet healthcare needs. Simultaneously it rededicates itself to its mission of creating healthier, happier communities across the globe.
Mission: To unlock new possibilities in life-sciences through quality healthcare solutions that impact lives.
Vision: To be a global life-sciences company transforming lives through pathbreaking discoveries.
Zydus Lifesciences Ratings
based on 5.9k reviews
Overall Rating
4.1/5
How AmbitionBox ratings work?
5
3.1k
4
1.5k
3
643
2
261
1
414
Category Ratings
4.0
Salary
4.0
Skill development
3.9
Job security
3.8
Company culture
3.8
Work-life balance
3.8
Work satisfaction
3.7
Promotions
Zydus Lifesciences is rated 4.1 out of 5 stars on AmbitionBox, based on 5.9k company reviews. This rating reflects a generally positive employee experience, indicating satisfaction with the company’s work culture, benefits, and career growth opportunities. AmbitionBox gathers authentic employee reviews and ratings, making it a trusted platform for job seekers and employees in India.
Read more
Gender Based Ratings at Zydus Lifesciences
based on 5.3k reviews
4.0
Rated by 385 Women
Rated 4.0 for Job security and 3.9 for Skill development
4.1
Rated by 4.9k Men
Rated 4.0 for Salary and 4.0 for Skill development
Work Policy at Zydus Lifesciences
based on 579 reviews in last 6 months
Work from office
83%
Hybrid
10%
Permanent work from home
7%
Zydus Lifesciences Reviews
Top mentions in Zydus Lifesciences Reviews
+ 5 more
Compare Zydus Lifesciences with Similar Companies
![]() | ![]() Change Company | ![]() Change Company | ![]() Change Company | |
---|---|---|---|---|
Overall Rating | 4.1/5 based on 5.9k reviews | 4.0/5 based on 5.7k reviews ![]() | 4.1/5 based on 6.8k reviews ![]() | 5.0/5 based on 1 reviews |
Highly Rated for | Skill development Salary Job security | Salary Skill development Job security | Skill development Salary Work-life balance | Skill development Work-life balance Salary |
Critically Rated for | ![]() No critically rated category | ![]() No critically rated category | ![]() No critically rated category | ![]() No critically rated category |
Primary Work Policy | Work from office 83% employees reported | Work from office 82% employees reported | Work from office 72% employees reported | - |
Rating by Women Employees | 4.0 Good rated by 385 women | 4.0 Good rated by 431 women | 4.1 Good rated by 668 women | - no rating available |
Rating by Men Employees | 4.1 Good rated by 4.9k men | 4.0 Good rated by 5k men | 4.1 Good rated by 5.7k men | - no rating available |
Job security | 3.9 Good | 3.8 Good | 3.7 Good | 4.0 Good |
View more
Zydus Lifesciences Salaries
Zydus Lifesciences salaries have received with an average score of 4.0 out of 5 by 5.9k employees.
Deputy Manager
(868 salaries)
Unlock
₹5.8 L/yr - ₹18.6 L/yr
Officer
(830 salaries)
Unlock
₹1.6 L/yr - ₹6.2 L/yr
Technical Assistant
(288 salaries)
Unlock
₹1.8 L/yr - ₹7.2 L/yr
Area Business Manager
(221 salaries)
Unlock
₹3.8 L/yr - ₹12 L/yr
Production Officer
(210 salaries)
Unlock
₹1.2 L/yr - ₹5.4 L/yr
Research Associate
(202 salaries)
Unlock
₹1.8 L/yr - ₹9.6 L/yr
Medical Representative
(194 salaries)
Unlock
₹1.6 L/yr - ₹6.5 L/yr
Senior Associate
(181 salaries)
Unlock
₹2.7 L/yr - ₹10.5 L/yr
Executive Production
(169 salaries)
Unlock
₹3.1 L/yr - ₹7.9 L/yr
Therapy Manager
(145 salaries)
Unlock
₹3.4 L/yr - ₹11.2 L/yr
Zydus Lifesciences Interview Questions
Interview questions by designation
Top Zydus Lifesciences interview questions and answers
Get interview-ready with top interview questions
Zydus Lifesciences Jobs
Popular Designations Zydus Lifesciences Hires for
Popular Skills Zydus Lifesciences Hires for
Current Openings
Zydus Lifesciences News
View all
Zydus Lifesciences Q3 Review — One Offs Impact Margins; Systematix Recommends 'Hold', Revises Target Price
- Zydus Lifesciences Q3 revenue stood at Rs 52,691 million, up 17.0% YoY.
- One-offs impact margins; competition causes decline in Asacol HD sales.
- Systematix recommends 'Hold' and revises target price for Zydus Lifesciences.
- Pivotal clinical data on Saroglitazar in primary biliary cholangitis to shape long-term growth opportunity.
Bloomberg Quint | 6 Feb, 2025
![Zydus Lifesciences Q3 Review — One Offs Impact Margins; Systematix Recommends 'Hold', Revises Target Price](https://media.assettype.com/bloombergquint%2F2023-02%2F984b7d1c-2ce9-4139-8fb6-61204fff24fb%2FZydus_Lifesciences_Ltd___Source_Company_website__png_3.png?rect=0%2C0%2C457%2C240&w=1200&auto=format%2Ccompress&ogImage=true)
Titan, Info Edge, Happiest Minds, J Kumar, V-Mart, Symphony, Birla Corp. And More Q3 Review — HDFC Securities
- Happies Minds Technologies Ltd. posted a weak quarter, with both revenue and margins coming in lower than our expectations.
- Titan, Symphony, and V-Mart are recommended as 'Reduce' by HDFC Securities.
- InfoEdge and Birla Corp are recommended as 'Buy' by HDFC Securities.
- Zydus Lifesciences, Metropolis, Max Financial, and J Kumar Infra are recommended as 'Add' by HDFC Securities.
Bloomberg Quint | 6 Feb, 2025
![Titan, Info Edge, Happiest Minds, J Kumar, V-Mart, Symphony, Birla Corp. And More Q3 Review — HDFC Securities](https://media.assettype.com/bloombergquint%2F2025-01-07%2Fdlbd3qdv%2Ftrader-woman-studying-stock-market-business-soft-2023-11-27-05-29-03-utc.jpg?rect=0%2C0%2C3489%2C1832&w=1200&auto=format%2Ccompress&ogImage=true)
Zydus Lifesciences posts 30% jump in Q3 profit on strong US sales
- Zydus Lifesciences has reported a 30% increase in Q3 profit on the back of strong US sales.
- The company's US formulations business saw a significant 31% growth to ₹2,409.6 crore, contributing 47% of consolidated revenues.
- The India business recorded a 7% growth to ₹1,947 crore, contributing 38% of total revenues.
- Zydus received FDA approval to conduct Phase II(b) clinical trials of Usnoflast for Amyotrophic Lateral Sclerosis (ALS).
HinduBusinessLine | 5 Feb, 2025
![Zydus Lifesciences posts 30% jump in Q3 profit on strong US sales](https://bl-i.thgim.com/public/incoming/z5p1sh/article69183412.ece/alternates/LANDSCAPE_1200/PO19_Zydus.jpg)
Q3 Results Live: Swiggy, Zydus Lifesciences, Gujarat Gas Among Major Earnings On Investors' Radar
- A total of 124 companies will declare their financial results for the quarter ending December 2024.
- Zydus Lifesciences, Swiggy, and Sula Vineyards will also announce their Q3 results.
- Zydus Lifesciences Ltd. is expected to have a revenue of Rs 5,204 crore with a net profit of Rs 893 crore.
- Cummins India Ltd. is estimated to have an Ebitda of Rs 554 crore, with a profit of Rs 452 crore.
Bloomberg Quint | 5 Feb, 2025
![Q3 Results Live: Swiggy, Zydus Lifesciences, Gujarat Gas Among Major Earnings On Investors' Radar](https://media.assettype.com/bloombergquint%2F2025-01-30%2Ftu256twb%2FWhatsApp-Image-2025-01-30-at-09.33.1332605f06.jpg?rect=0%2C0%2C1280%2C672&w=1200&auto=format%2Ccompress&ogImage=true)
Stocks that will see action today: January 23, 2025
- Housing and Urban Development Corporation Ltd signs MoU with VPPL for development of ports/PPP projects.
- Zydus Lifesciences receives Orphan Drug Designation for Usnoflast for the treatment of amyotrophic lateral sclerosis.
- Waaree Energies starts commercial production of solar modules in its US manufacturing facility.
- Piramal Critical Care launches Chlorpromazine Hydrochloride for Injection in the US.
HinduBusinessLine | 23 Jan, 2025
![Stocks that will see action today: January 23, 2025](https://bl-i.thgim.com/public/incoming/7unswv/article68557356.ece/alternates/LANDSCAPE_1200/buzzing%20stocks.jpg)
Stocks To Watch Today: Jio Financial Services, Medplus Health, JK Tyre, HCLTech
- Jio Financial Services and BlackRock subscribed to Rs 5.85 crore shares of JV Jio BlackRock Asset Management for Rs 117 crore.
- Medplus Health's arm received three suspension orders of drug license for a store in Karnataka.
- Neuland Laboratories approved a capital expenditure of Rs 342 crore in two facilities.
- Other stocks to watch include JK Tyre Industries, Centum Electronics, HCL Technologies, Tanla Platforms, Vodafone Idea, Zydus Lifesciences, and Vedanta.
Bloomberg Quint | 22 Jan, 2025
![Stocks To Watch Today: Jio Financial Services, Medplus Health, JK Tyre, HCLTech](https://media.assettype.com/bloombergquint%2F2024-03%2Fb6ada3be-b77e-41d8-b7ba-40c3c6ce60d0%2FStock_Unsplash.jpg?rect=0%2C0%2C870%2C457&w=1200&auto=format%2Ccompress&ogImage=true)
Stocks To Watch Today: Hero MotoCorp, Ola Electric, Senores Pharma, JSW Energy, Max Financial
- Hero MotoCorp extended its partnership with Harley-Davidson Motor to expand the Harley-Davidson X440 into new variants, while rival Ola Electric has seen two senior executives quit.
- JSW Energy’s arm JSW Neo Energy acquired a large renewable energy platform for Rs 12,468 crore.
- The market will also buzz with the listing of three companies—Senores Pharma Ltd., Carraro India Ltd., and Ventive Hospitality Ltd.
- IOL Chemicals and Pharma, Prestige Estates, Utkarsh Small Finance Bank, and Zydus Life are some of the other stocks to watch on Monday.
Bloomberg Quint | 30 Dec, 2024
![Stocks To Watch Today: Hero MotoCorp, Ola Electric, Senores Pharma, JSW Energy, Max Financial](https://media.assettype.com/bloombergquint%2F2024-12-27%2Foo4sm7qg%2Fbusiness-finance-with-report-document-2024-10-18-04-59-43-utc-1.jpg?w=1200&auto=format%2Ccompress&ogImage=true)
Zydus gets USFDA nod for local anesthetic cream
- Zydus Lifesciences has received approval from the USFDA for its topical anesthetic cream.
- The cream is used for local pain relief during minor surgical procedures.
- The cream has recorded annual sales of $22.05 million in the United States.
- This approval marks Zydus's 412th USFDA approval since FY 2003-04.
HinduBusinessLine | 19 Dec, 2024
![Zydus gets USFDA nod for local anesthetic cream](https://bl-i.thgim.com/public/incoming/hk4a43/article69004049.ece/alternates/LANDSCAPE_1200/CCI_UDHindu_KSL_U295IN0UV_R1552649758_7_4afa040a-703b-4fd1-86d3-9c35286f7340.jpg)
Aurobindo Pharma, Glenmark, Zydus Recall Products In US
- Drug makers Aurobindo Pharma, Glenmark, and Zydus are recalling products in the US market due to manufacturing issues.
- Aurobindo Pharma USA Inc. is recalling over 1 lakh bottles of Cinacalcet tablets due to the presence of N-nitroso Cinacalcet impurity above FDA recommended limit.
- Glenmark Pharmaceuticals Inc, USA is recalling around 90,000 bottles of Diltiazem Hydrochloride extended-release capsules due to the presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended limit.
- Zydus Pharmaceuticals (USA) Inc is recalling 4,404 packs of Esomeprazole Magnesium for Delayed-Release Oral Suspension due to a labeling error.
Bloomberg Quint | 15 Dec, 2024
![Aurobindo Pharma, Glenmark, Zydus Recall Products In US](https://media.assettype.com/bloombergquint%2F2024-11-27%2Fcd69cmfx%2Fchristina-victoria-craft-WHSnkIwWpec-unsplash.jpg?rect=0%2C72%2C3869%2C2031&w=1200&auto=format%2Ccompress&ogImage=true)
Nifty Pharma, Healthcare Snap Two-Day Fall Post Jefferies' Outlook
- Nifty Pharma and Nifty Healthcare snapped their two-day fall and rose on Tuesday, following a report by Jefferies on its takeaways from its tour of pharma companies across Delhi, Mumbai, and Hyderabad.
- The report mentioned that non-price metrics are being given due importance for supplier selection and hospitals are looking to add new geographies once the home turf is well protected.
- Indian generic firms with meaningful exposure to the US market are adopting different strategies to avoid price erosion, such as moving up the value chain and pursuing complex products.
- In Nifty Healthcare, Glenmark Pharma, Syngene International, and Apollo Hospitals were among the top gainers, while Dr Reddy's Labs, Zydus Lifesciences, and Aurobindo Pharma fell the most.
Bloomberg Quint | 10 Dec, 2024
![Nifty Pharma, Healthcare Snap Two-Day Fall Post Jefferies' Outlook](https://media.assettype.com/bloombergquint%2F2024-12-10%2F2qmhe56k%2Fisaac-quesada-Loahp7cXIf4-unsplash.jpg?rect=0%2C304%2C5472%2C2873&w=1200&auto=format%2Ccompress&ogImage=true)
Powered by
Zydus Lifesciences Subsidiaries
Zydus Healthcare
4.0
• 618 reviews
Zydus Hospital
4.3
• 239 reviews
German Remedies
3.9
• 87 reviews
Zydus Animal Health
3.7
• 58 reviews
Liva Pharmaceuticals
3.5
• 39 reviews
BIOCHEM PHARMACEUTICALS
4.2
• 12 reviews
Report error
Compare Zydus Lifesciences with
Biocon Limited
3.9
Torrent Pharmaceuticals
3.9
Lupin
4.2
Glenmark Pharmaceuticals
3.9
Aurobindo Pharma
4.0
DIVI'S Laboratories
3.8
Alembic Pharmaceuticals
4.0
Dr. Reddy's
4.1
Intas Pharmaceuticals
4.1
Hetero
3.9
Viatris
4.2
Abbott
4.1
Alkem Laboratories
3.9
Ipca Laboratories
3.9
MSN Laboratories
3.7
Ajanta Pharma
4.1
Akums Drugs & Pharmaceuticals Limited
4.4
Cadila Pharmaceuticals
3.5
GlaxoSmithKline Pharmaceuticals
4.1
Pfizer
4.0
Contribute & help others!
You can choose to be anonymous
Write a review
Share interview
Contribute salary
Add office photos
Companies Similar to Zydus Lifesciences
Sun Pharmaceutical Industries
Healthcare / Pharma, Manufacturing, Analytics & KPO, Pharma
4.0
• 5.7k reviews
Cipla
Manufacturing, Pharma
4.1
• 6.8k reviews
DRJ & CO
Architecture & Interior Design
5.0
• 1 reviews
Biocon Limited
Biotech & Life sciences, Biotechnology
3.9
• 1.9k reviews
Torrent Pharmaceuticals
Pharma
3.9
• 2.5k reviews
Lupin
Biotech & Life sciences, Manufacturing, Pharma
4.2
• 6k reviews
Glenmark Pharmaceuticals
Pharma
3.9
• 2.8k reviews
Aurobindo Pharma
Healthcare / Pharma, Biotechnology, Pharma
4.0
• 4.7k reviews
DIVI'S Laboratories
Pharma
3.8
• 1.4k reviews
Alembic Pharmaceuticals
Real Estate, Engineering & Construction, Biotechnology, Pharma
4.0
• 3k reviews
Dr. Reddy's
Clinical Research, Pharma
4.1
• 6.7k reviews
Intas Pharmaceuticals
Biotech & Life sciences, Pharma
4.1
• 3.4k reviews
Zydus Lifesciences FAQs
When was Zydus Lifesciences founded?
Zydus Lifesciences was founded in 1952. The company has been operating for 73 years primarily in the Pharma sector.
Where is the Zydus Lifesciences headquarters located?
Zydus Lifesciences is headquartered in Ahmedabad, India. It operates in 2 cities such as Ahmedabad, Mumbai. To explore all the office locations, visit Zydus Lifesciences locations.
How many employees does Zydus Lifesciences have in India?
Zydus Lifesciences currently has more than 26,000+ employees in India. Production, Manufacturing & Engineering department appears to have the highest employee count in Zydus Lifesciences based on the number of reviews submitted on AmbitionBox.
Does Zydus Lifesciences have good work-life balance?
Zydus Lifesciences has a Work-Life Balance Rating of 3.8 out of 5 based on 5,900+ employee reviews on AmbitionBox. 78% employees rated Zydus Lifesciences 4 or above, while 22% employees rated it 3 or below on work-life balance. This indicates that the majority of employees feel a generally balanced work-life experience, with some opportunities for improvement based on the feedback. We encourage you to read Zydus Lifesciences work-life balance reviews for more details
Is Zydus Lifesciences good for career growth?
Career growth at Zydus Lifesciences is rated fairly well, with a promotions and appraisal rating of 3.7. 78% employees rated Zydus Lifesciences 4 or above, while 22% employees rated it 3 or below on promotions/appraisal. Though the sentiment is mixed for career growth, majority employees have rated it positively. We recommend reading Zydus Lifesciences promotions/appraisals reviews for more detailed insights.
What are the pros of working in Zydus Lifesciences?
Working at Zydus Lifesciences offers several advantages that make it an appealing place for employees. The company is highly rated for salary & benefits, skill development and job security, based on 5,900+ employee reviews on AmbitionBox.
Stay ahead in your career. Get AmbitionBox app
Helping over 1 Crore job seekers every month in choosing their right fit company
70 Lakh+
Reviews
5 Lakh+
Interviews
4 Crore+
Salaries
1 Cr+
Users/Month
Contribute to help millions
Get AmbitionBox app